Cabrini Research Forum - November 2026
Welcome to the Cabrini Research Forum, a celebration of innovation, collaboration, and excellence in research and quality improvement across Cabrini!
Throughout November, explore a diverse range of projects being led by our clinicians, nurses, allied health professionals, researchers, students and quality improvement teams. The posters are grouped into themed categories, showcasing the breadth of work being done to improve patient care, advance clinical practice, and contribute to healthcare knowledge.
This year’s event is open to all hospital staff, clinicians, researchers and the public, inviting everyone to discover the remarkable projects taking place across our organisation — and to have their say!
Cast your vote for the People’s Choice Award at the bottom of the page and go into the draw to win a prize. Your participation helps recognise and support the dedication of our teams.
Join us in celebrating the incredible work happening across Cabrini — and be inspired by the difference we’re making together.
Explore. Learn. Vote. Win. Celebrate research and quality improvement in healthcare!
Explore the research and quality improvement projects by theme below
Colorectal cancer during pregnancy: a systematic review and pooled case-level analysis.
– Dr Katherine Goodall
Smoking status and outcomes after colorectal cancer surgery in an Australian cohort.
– Dr Katherine Goodall
Sex-based differences in perioperative outcomes but not long-term survival outcomes after Stage IV colorectal cancer surgery.
– Dr Katherine Goodall
How does prognosis change after colorectal cancer surgery? Dynamic prediction over time.
– A/Prof Mohammad Asghari-Jafarabadi
Predicting cancer and non-cancer death after colorectal cancer surgery.
– A/Prof Mohammad Asghari-Jafarabadi
Age-related differences in colorectal cancer (CRC) presentation, treatment and relapse.
– Archie Musafir
Does delayed systemic therapy affect survival after stage IV colorectal cancer resection?
– Dr Simon Wilkins
Urinary di(2-ethylhexyl) phthalate (DEHP) metabolites and breast cancer risk: a systematic review and meta-analysis.
– Dr Feras Alnimri
Retrospective cohort review on the significance of pattern 3 positive margins in radical prostatectomy specimens.
– Thomas Read
Treatment and survival outcomes for Indigenous and non‐Indigenous Australians within the Victorian Lung Cancer Registry: a retrospective cross‐sectional cohort study.
– Prof Gary Richardson
MDSLink: Update on diagnoses, treatments and clinical outcomes from a Myelodysplastic Syndromes Registry
– Zaira Nosaibah
Meta-analysis: Should medical therapy be withdrawn after achievement of STRIDE-II treatment targets in ulcerative colitis?
– Dr Shahed Kamal
AI Scribe: improving efficiency in nursing assessment emergency department pilot study.
– Jessica Clifford
From data to action: how applied learning health systems turn clinical data into knowledge.
– Patience Onuogu
Can machine learning improve survival prediction after colorectal cancer surgery?
– A/Prof Mohammad Asghari-Jafarabadi
Evaluation of a modified proprietary electronic patient reported outcome measures tool for monitoring toxicities associated with systemic chemotherapy.
– Prof Gary Richardson
Exercise during immune checkpoint inhibitor treatment for melanoma: protocol for a randomised controlled trial.
– Megan Sohtra
Exercise for cancer patients receiving immune checkpoint inhibitors: healthcare professional views and practices.
– Megan Sohtra
Feasibility of live remote exercise for adults with advanced cancer and cachexia.
– A/Prof Eva Zopf
Establishing patient-derived ovarian cancer organoids as a preclinical model of ovarian cancer.
– Dr Sylvia Mahara
Biomarker-driven therapies for patients with persistent/recurrent rare epithelial ovarian carcinomas: ENGOT-GYN2/GOG-3051/BOUQUET phase 2 study results.
– Prof Gary Richardson
Azenosertib plus paclitaxel for platinum-resistant ovarian cancer: results from a phase 1b study.
– Prof Gary Richardson
Elisrasib (D3S-001) monotherapy in advanced KRAS G12C-mutant solid tumours.
– Prof Gary Richardson
A phase 1/2 study of surzebiclimab in combination with tislelizumab with or without LBL-007 in advanced solid tumours.
– Prof Gary Richardson
Clinical evaluation of first in vivo mRNA-LNP TROP2-directed CAR, MT-302, in solid tumours.
– Prof Gary Richardson
Implementation of oncologist-led delivery of tumour genomic sequencing via circulating tumour DNA to patients with metastatic solid tumours: a multimodality study.
– Prof Gary Richardson
A phase 1, first-in-human study of TAK-280, a B7-H3 × CD3ε COBRA T-cell engager, in adult patients with unresectable, locally advanced, or metastatic solid tumors.
– Prof Gary Richardson
Azenosertib in combination with bevacizumab as maintenance therapy in patients with advanced ovarian cancer: part 2 of a phase 1b study (MUIR/Zn-c3-002)
– Prof Gary Richardson
Self-reported confidence in cytokine release syndrome (CRS) at Cabrini Hospital.
– Lucy Doquile
Beyond the Beep: Exploring music as therapy in the ICU.
– Anne Julie Arulnathan and Dr James Ho
Understanding smart pump guardrails compliance in the paediatric department at a single site: a quality improvement survey.
– Jian Wu Tan
Implementing a low back pain clinical pathway in a private emergency department along with clinician education in accordance with the Australian low back pain clinical care standard to improve quality and safety of care: a mixed-methods, quasi-experimental study.
– James Sherwood
Clinical supervision, a reflective approach to complex leadership challenges.
– Beth Gleisner
Improving compliance with supervision documentation in dysphagia management: education development and staff knowledge evaluation.
– Madeleine Ebinger
Exploring efficacy of education delivery methods during in-service time: a prospective study comparing lectures and in-situ simulation and their effects on patient assessment.
– Megan Hayes